This was the stock's second consecutive day of gains.

PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced an ...

NEW YORK, NY / ACCESSWIRE / January 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Sangamo ...

In a report released yesterday, Jasper Hellweg from Argus Research maintained a Hold rating on Viatris (VTRS – Research Report). The company’s ...

Pfizer Inc. closed $4.65 short of its 52-week high ($31.54), which the company reached on July 30th.

We see every single bet.' ...

Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...

The new $467 million includes $400 million in royalties for the Pfizer-BioNTech vaccine from 2020 through 2023.

Sangamo Therapeutics said on Monday that partner Pfizer has terminated their hemophilia A gene therapy co-development ...

"Federal law requires defendants to ensure that their drug labels remain accurate, and when new scientific information ...

INR:2383. bts logo Zai Lab announces 2020 annual report: Commercial products expected to increase to four this year The National Health Commission issued a document stat ...

BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University ...